2023 Neuren Pharmaceuticals Update

Explore Neuren Pharmaceuticals’ latest updates on their clinical development program for Angelman Syndrome, including progress on Trofinetide and NNZ-2591 treatments.

2023 Ionis Pharmaceuticals Update

Explore Ionis Pharmaceuticals’ commitment to developing treatments for Angelman Syndrome, their progress in the HALOS clinical trial, and their dedication to genetic medicine.

2023 ASF Virtual Conference – Intro

Join the 2023 ASF Virtual Conference! Discover our achievements, future plans, and how you can help support the Angelman Syndrome Foundation. Enjoy at your convenience.

Q&A about the ACES-ICT – Inclusion program

Explore the ACES-ICT inclusion program at PS15 with teachers Rachel Marks and Catherine Lipkin. Learn about the power of inclusion in education and how it benefits all students.